Morgan Stanley Boosts Metlife (NYSE:MET) Price Target to $53.00

Share on StockTwits

Metlife (NYSE:MET) had its price objective lifted by Morgan Stanley from $52.00 to $53.00 in a report published on Wednesday, Stock Target Advisor reports. The brokerage currently has an equal weight rating on the financial services provider’s stock.

A number of other equities research analysts also recently issued reports on the stock. Barclays set a $34.00 price objective on shares of DCP Midstream and gave the stock a hold rating in a research note on Wednesday, May 22nd. ValuEngine upgraded shares of Yirendai from a strong sell rating to a sell rating in a research report on Friday, May 3rd. Sandler O’Neill lowered shares of Metlife from a buy rating to a hold rating and set a $50.00 price target on the stock. in a research report on Tuesday, March 19th. Wells Fargo & Co reissued a buy rating and issued a $55.00 price objective on shares of Metlife in a research note on Wednesday, June 5th. Finally, Deutsche Bank boosted their price objective on shares of Prudential Financial from $97.00 to $104.00 and gave the company a hold rating in a research report on Friday, April 12th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of Hold and a consensus target price of $50.67.

Metlife stock opened at $50.92 on Wednesday. The company has a market cap of $47.92 billion, a price-to-earnings ratio of 9.45, a PEG ratio of 1.07 and a beta of 1.10. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.14 and a current ratio of 0.14. The business’s fifty day moving average is $48.82. Metlife has a one year low of $37.76 and a one year high of $50.94.

Metlife (NYSE:MET) last released its earnings results on Wednesday, May 1st. The financial services provider reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.18. Metlife had a return on equity of 10.20% and a net margin of 7.56%. The company had revenue of $15.45 billion for the quarter, compared to analyst estimates of $15.95 billion. During the same period in the prior year, the firm posted $1.36 EPS. Metlife’s quarterly revenue was up 2.0% on a year-over-year basis. On average, equities analysts expect that Metlife will post 5.59 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Tuesday, August 6th will be paid a $0.44 dividend. The ex-dividend date of this dividend is Monday, August 5th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.46%. Metlife’s payout ratio is currently 32.65%.

A number of hedge funds have recently added to or reduced their stakes in the stock. Cutler Capital Management LLC raised its holdings in shares of Metlife by 11.5% in the fourth quarter. Cutler Capital Management LLC now owns 178,103 shares of the financial services provider’s stock valued at $7,313,000 after acquiring an additional 18,425 shares in the last quarter. Deprince Race & Zollo Inc. raised its stake in Metlife by 0.3% in the 4th quarter. Deprince Race & Zollo Inc. now owns 506,580 shares of the financial services provider’s stock valued at $20,800,000 after purchasing an additional 1,590 shares during the last quarter. Van ECK Associates Corp raised its stake in Metlife by 2.0% in the 4th quarter. Van ECK Associates Corp now owns 14,357 shares of the financial services provider’s stock valued at $589,000 after purchasing an additional 276 shares during the last quarter. Bessemer Group Inc. raised its stake in Metlife by 25.4% in the 4th quarter. Bessemer Group Inc. now owns 17,666 shares of the financial services provider’s stock valued at $725,000 after purchasing an additional 3,577 shares during the last quarter. Finally, Berman Capital Advisors LLC acquired a new position in Metlife in the 4th quarter valued at $31,000. Institutional investors and hedge funds own 75.66% of the company’s stock.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: What is Put Option Volume?

Analyst Recommendations for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.